Abstract
Background: Shingles causes considerable morbidity in older persons. Zostavax, a vaccine against shingles, reduces the incidence of shingles by 50% and the burden of illness by two-thirds. Little is known about the factors that contribute to the patient's intention to get Zostavax.
Methods & Materials: A two stage simple random sampling process was undertaken to identify a random sample of GPs across two urban areas in South Australia to identify the key beliefs about shingles and its complications and the factors that may influence the uptake of the Zostavax.
| Original language | English |
|---|---|
| Pages (from-to) | 436-437 |
| Number of pages | 2 |
| Journal | International Journal of Infectious Diseases |
| Volume | 21 |
| Issue number | Supplement 1 |
| DOIs | |
| Publication status | Published - Apr 2014 |
| Event | 16th International Congress on Infectious Diseases - Cape Town, South Africa Duration: 2 Apr 2014 → 5 Apr 2014 Conference number: 16 |
Bibliographical note
This article is available under the Creative Commons CC-BY-NC-ND license and permits non-commercial use of the work as published, without adaptation or alteration provided the work is fully attributed.Keywords
- shingles
- vaccination
- vaccine
- older adults
- older persons
Fingerprint Dive into the research topics of 'Australian zoster study: GP and patient views about herpes zoster (shingles), its complications, and the likely acceptance of a zoster vaccine'. Together they form a unique fingerprint.
Cite this
Litt, J., Kim, S., Woodman, R., MacIntyre, R., & Cunningham, T. (2014). Australian zoster study: GP and patient views about herpes zoster (shingles), its complications, and the likely acceptance of a zoster vaccine. International Journal of Infectious Diseases, 21(Supplement 1), 436-437. https://doi.org/10.1016/j.ijid.2014.03.1320